Lanzhou Foci Pharmaceutical Co.Ltd(002644) : third quarter report 2021 (Updated)

Lanzhou Foci Pharmaceutical Co.Ltd(002644)

Third quarter report 2021

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Important content tips: 1 The board of directors, the board of supervisors, directors, supervisors and senior managers guarantee that the quarterly report is true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities. 2. The person in charge of the company, the person in charge of accounting and the person in charge of the accounting organization (Accounting Supervisor) declare that they guarantee the authenticity, accuracy and completeness of the financial information in the quarterly report. 3. Whether the third quarter report has been audited □ yes √ No 1. Main financial data (I) whether the company needs to retroactively adjust or restate the accounting data of previous years □ yes √ no

During the reporting period, the reporting period increased from the beginning of the year to the end of the reporting period, and decreased from the beginning of the year to the end of the reporting period

Operating income (yuan): 27734393775 59.56% 66417047525 32.22%

2221154924 – 64.58% 7077854751 – 32.70% net profit (yuan) attributable to shareholders of listed companies

Net profit after deducting non recurring profit and loss 1941 Sunwoda Electronic Co.Ltd(300207) 335.43% 4790399930 122.28% (yuan)

Cash flow from operating activities – 7717298983 80.21% net amount (yuan)

Basic earnings per share (yuan / share) 0.0435129.33% 0.1386 – 32.70%

Diluted earnings per share (yuan / share) 0.0435129.33% 0.1386 – 32.70%

Weighted average return on net assets 1.39%, 130.30%, 4.43% – 32.88%

Increase or decrease at the end of the reporting period compared with the end of the previous year

Total assets (yuan): 251221738444238718179219 5.24%

158758461473158209069992 0.35% owner’s equity attributable to shareholders of listed companies (yuan) (II) non recurring profit and loss items and amount √ applicable □ not applicable

Unit: Yuan

Description of project amount from the beginning of the reporting period to the end of the reporting period

forehead

Government subsidies included in current profits and losses (compared with the normal business of the company)

Closely related, in line with national policies and regulations, 4784415562662353735 government subsidies are determined according to certain standards

(except for government subsidies continuously enjoyed in amount or quota)

Other non operating income and expenditure other than the above items 1090587228769584

Less: income tax impact 73402114403668498

Total 5441587421–

Details of other profit and loss items that meet the definition of non recurring profit and loss: □ applicable √ not applicable. The company does not have details of other profit and loss items that meet the definition of non recurring profit and loss. Description of defining the non recurring profit and loss items listed in the explanatory announcement on information disclosure of companies offering securities to the public No. 1 – non recurring profit and loss as recurring profit and loss items □ applicable √ not applicable the company does not have the explanatory announcement on information disclosure of companies offering securities to the public No. 1 – non recurring profit and loss The non recurring profit and loss items listed in are defined as recurring profit and loss items. (3) Changes and reasons of main accounting data and financial indicators √ applicable □ not applicable 1. Balance sheet items

Project ending balance (yuan) opening balance (yuan) change range change reason

Accounts receivable 3907753564818175295019 increased by 115.00% compared with the beginning of the period, mainly due to sales growth.

Accounts receivable financing 288943471313155570990 decreased compared with the beginning of the period, mainly due to the due settlement or endorsement payment of notes receivable – 78.04%.

The increase of advance payment 50454436761717304168 compared with the beginning of the period is mainly due to the advance payment from the supplier for the purchase of 193.80% scarce raw materials such as donkey skin and bezoar.

Other receivables increased by 2339809966 and 458343668 compared with the beginning of the period, mainly due to the increase of reserve fund paid to 410.49% of marketing personnel in the current period to increase product sales.

The reason for the decrease of short-term bank borrowings is – 2240000% compared with the beginning of the period.

Notes payable 2900 China Vanke Co.Ltd(000002) 643000000 decreased compared with the beginning of the period, which is due to the fact that – 89.03% of the bills receivable are used for payment of goods and engineering funds, which are paid according to endorsement.

Accounts payable 3728691688827377670505 36.19% higher than that at the beginning of the period, mainly due to the increase of Engineering accounts payable.

The increase of employee salary payable of 1707681863 and 805478155 compared with the beginning of the period is mainly to strengthen sales. 112.01% of the salespeople invested in the current period increased, and the accrued performance salary increased.

2. Income statement items

Amount of the project in the current period (yuan) change range of amount in the previous period (yuan) change reason

The operating income was 6641704752550230485412, an increase of 32.22% over the previous period, mainly due to the sales growth of this year.

The operating cost was 46686462883, 36613533353 and 27.51% higher than that of the previous period, mainly due to the increase of sales.

The increase of sales expenses compared with the previous period was mainly due to the increase of sales, and the market allocation expenses increased by 94147116206215775310 and 51.46%.

The investment income increased by 125724536 – 277215550 – 145.35% compared with the previous period, mainly because the participating companies realized profits in the current period.

The asset disposal income of 7048840603 decreased compared with the previous period, which was due to the disposal of land in the same period of last year, and -100.00% was not paid in the current period.

3. Cash flow statement items

Amount of the project in the current period (yuan) change range of amount in the previous period (yuan) change reason

The increase of 7717298983 – 152 Wave Cyber (Shanghai) Co.Ltd(688718) 5 from operating activities compared with the previous period is mainly due to the increase of 605.43% in cash flow related to sales.

Net cash flow

The current -7645987337 -2687419434 generated by investment activities decreased compared with the previous period, mainly because the settlement of projects in the new area is nearing the end, and the payment of Engineering – 184.51% is increased.

Net cash flow

The current -8802975983 – 1841854878 from financing activities decreased compared with the previous period, mainly due to the repayment of bank short-term loans and the increase of dividend distribution of – 377.94%.

Net cash flow

Cash and cash equivalents decreased by -8731664337 – 6055363889 – 44.20% compared with the same period of last year, which is the result of the joint action of the above factors. Net increase II. Shareholder information (I) total number of ordinary shareholders, number of preferred shareholders with voting rights restored and shareholding of the top ten shareholders

Unit: shares

Total number of common shareholders at the end of the reporting period priority of voting rights restoration at the end of the reporting period

Total number of shareholders of 28662 shares (if any) 0

Shareholding of top 10 shareholders

Name of shareholder

- Advertisment -